257 related articles for article (PubMed ID: 9010559)
41. [Eosinophil activation evaluated by using a anti-human secreted form of ECP antibody (EG2)].
Kobayashi H; Maeda S; Tamura M; Sakamoto S
Nihon Rinsho; 1993 Mar; 51(3):626-30. PubMed ID: 8492435
[TBL] [Abstract][Full Text] [Related]
42. [The role of eosinophilic granulocytes for the pathogenesis of atopic dermatitis /neurodermatitis. Eosinophilic products as markers of disease activity].
Kapp A
Hautarzt; 1993 Jul; 44(7):432-6. PubMed ID: 8365876
[TBL] [Abstract][Full Text] [Related]
43. Sustained eosinophil cationic protein release into tears after a single high-dose conjunctival allergen challenge.
Montan PG; van Hage-Hamsten M; Zetterström O
Clin Exp Allergy; 1996 Oct; 26(10):1125-30. PubMed ID: 8911697
[TBL] [Abstract][Full Text] [Related]
44. Blood eosinophil number and activity in relation to lung function in patients with asthma and with eosinophilia.
Griffin E; Håkansson L; Formgren H; Jörgensen K; Peterson C; Venge P
J Allergy Clin Immunol; 1991 Feb; 87(2):548-57. PubMed ID: 1847158
[TBL] [Abstract][Full Text] [Related]
45. Total blood eosinophils, serum eosinophil cationic protein and eosinophil protein X in childhood asthma: relation to disease status and therapy.
Zimmerman B; Lanner A; Enander I; Zimmerman RS; Peterson CG; Ahlstedt S
Clin Exp Allergy; 1993 Jul; 23(7):564-70. PubMed ID: 8221257
[TBL] [Abstract][Full Text] [Related]
46. Airway eosinophilic inflammation, epithelial damage, and bronchial hyperresponsiveness in patients with mild-moderate, stable asthma.
Oddera S; Silvestri M; Balbo A; Jovovich BO; Penna R; Crimi E; Rossi GA
Allergy; 1996 Feb; 51(2):100-7. PubMed ID: 8738515
[TBL] [Abstract][Full Text] [Related]
47. Eosinophilic inflammation in asthma.
Bousquet J; Chanez P; Lacoste JY; Barnéon G; Ghavanian N; Enander I; Venge P; Ahlstedt S; Simony-Lafontaine J; Godard P
N Engl J Med; 1990 Oct; 323(15):1033-9. PubMed ID: 2215562
[TBL] [Abstract][Full Text] [Related]
48. Eosinophils and eosinophil cationic protein in children with and without sensitization to inhalant allergens.
Kuehr J; Frischer T; Barth R; Karmaus W; Krüger S; Meinert R; Urbanek R; Forster J
Eur J Pediatr; 1994 Oct; 153(10):739-44. PubMed ID: 7813532
[TBL] [Abstract][Full Text] [Related]
49. Individual time-courses of ECP and EPX during allergen provocation tests in asthmatic children.
Kleinau I; Niggemann B; Wahn U
Pediatr Allergy Immunol; 1995 May; 6(2):109-18. PubMed ID: 7581720
[TBL] [Abstract][Full Text] [Related]
50. Effects of immunotherapy on the inflammation in pollen asthma.
Rak S
Allergy; 1993; 48(17 Suppl):125-8; discussion 143-4. PubMed ID: 8109703
[TBL] [Abstract][Full Text] [Related]
51. The eosinophilic injury to the mucosa of the airways in the pathogenesis of bronchial asthma.
Frigas E; Motojima S; Gleich GJ
Eur Respir J Suppl; 1991 Apr; 13():123s-135s. PubMed ID: 1953909
[TBL] [Abstract][Full Text] [Related]
52. Clinical value of monitoring eosinophil activity in asthma.
Koller DY; Herouy Y; Götz M; Hagel E; Urbanek R; Eichler I
Arch Dis Child; 1995 Nov; 73(5):413-7. PubMed ID: 8554357
[TBL] [Abstract][Full Text] [Related]
53. Effect of allergen avoidance at high altitude on direct and indirect bronchial hyperresponsiveness and markers of inflammation in children with allergic asthma.
van Velzen E; van den Bos JW; Benckhuijsen JA; van Essel T; de Bruijn R; Aalbers R
Thorax; 1996 Jun; 51(6):582-4. PubMed ID: 8693437
[TBL] [Abstract][Full Text] [Related]
54. Increased serum levels of eosinophil cationic protein and eosinophil-derived neurotoxin (protein X) in vernal keratoconjunctivitis.
Tomassini M; Magrini L; Bonini S; Lambiase A; Bonini S
Ophthalmology; 1994 Nov; 101(11):1808-11. PubMed ID: 7800361
[TBL] [Abstract][Full Text] [Related]
55. Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin.
Ackerman SJ; Loegering DA; Venge P; Olsson I; Harley JB; Fauci AS; Gleich GJ
J Immunol; 1983 Dec; 131(6):2977-82. PubMed ID: 6644025
[TBL] [Abstract][Full Text] [Related]
56. Eosinophil inflammation of the nasal mucosa in allergic and non-allergic rhinitis measured by eosinophil cationic protein levels in native nasal fluid and serum.
Rasp G; Thomas PA; Bujía J
Clin Exp Allergy; 1994 Dec; 24(12):1151-6. PubMed ID: 7889429
[TBL] [Abstract][Full Text] [Related]
57. Measurement of eosinophil cationic protein (ECP) and eosinophil protein X/eosinophil derived neurotoxin (EPX/EDN). Time and temperature dependent spontaneous release in vitro demands standardized sample processing.
Reimert CM; Poulsen LK; Bindslev-Jensen C; Kharazmi A; Bendtzen K
J Immunol Methods; 1993 Dec; 166(2):183-90. PubMed ID: 8288872
[TBL] [Abstract][Full Text] [Related]
58. Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators.
Sedgwick JB; Calhoun WJ; Gleich GJ; Kita H; Abrams JS; Schwartz LB; Volovitz B; Ben-Yaakov M; Busse WW
Am Rev Respir Dis; 1991 Dec; 144(6):1274-81. PubMed ID: 1741538
[TBL] [Abstract][Full Text] [Related]
59. Increased fecal eosinophil cationic protein in inflammatory bowel disease.
Berstad A; Børkje B; Riedel B; Elsayed S; Berstad A
Hepatogastroenterology; 1993 Jun; 40(3):276-8. PubMed ID: 8325594
[TBL] [Abstract][Full Text] [Related]
60. Effect of conditions in obtaining blood samples for ECP testing in children.
Pena JM; Rubira N; Botey J; Rodrigo MJ; Alonso R; Eseverri JL; Marín A; Ras RM
Allerg Immunol (Paris); 1996 Feb; 28(2):39-43. PubMed ID: 8703307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
